Search Results for 'acute lymphoid leukaemia'

Filter results by..

Type

All (55)

Briefing (9)

Editorial (1)

Guidance (1)

Presentation (5)

Report (9)

Webpage (30)

KEY MESSAGES: The greatest survival improvements for males and females of all ages are observed in Chronic Myeloid Leukaemia (CML). Increased use of effective treatment for CML since 2003 means survival for patients diagnosed more recently will be higher than reported here. Acute Lymphoblastic Leukaemia shows significant increases in survival in the 0-14 age group. Acute Myeloid Leukaemia and Chronic Lymphocytic Leukaemia have experienced no significant changes in survival over the period. Changes in coding and registration practice must be taken into account when interpreting changes in trends
1. Survival outcomes for different forms of leukaemia should be reported separately. The different cancers called ‘leukaemia’ vary in the groups they affect, in their overall severity and in their outcome. Grouped summary outcomes for leukaemia do not represent accurately the experience for any of the individual cancers. Apparent differences between areas can result from different levels of registration for different cancers. 2. Because of all of these reasons, reporting outcomes for ‘leukaemia’ as a group is misleading.
Survival rates for most, though not all, types of cancer have increased in recent years for both 0 - 14 and 15 - 24 year olds. This data briefing was prepared by the Childhood Cancer Research Group (CCRG) and the North West Cancer Intelligence Service (NWCIS).
KEY MESSAGES: The greatest survival improvements for males and females of all ages are observed in Chronic Myeloid Leukaemia (CML). Increased use of effective treatment for CML since 2003 means survival for patients diagnosed more recently will be higher than reported here. Acute Lymphoblastic Leukaemia shows significant increases in survival in the 0-14 age group. Acute Myeloid Leukaemia and Chronic Lymphocytic Leukaemia have experienced no significant changes in survival over the period. Changes in coding and registration practice must be taken into account when interpreting changes in trends
Presentation from the Cancer Outcomes Conference 2012
KEY MESSAGE: 30 day mortality and one year survival vary considerably by type of cancer in those aged 15-24 years. Patients with acute myeloid leukaemia have the highest proportion of early deaths, with 6.4% dying within 30 days of diagnosis and 77% surviving the first year.
1  2  3  4  5  6